Therapeutic antibodies
from EU-approved medicines

Currently, we offer 23 different therapeutic monoclonal antibodies from EU licensed drugs for use in R&D, preclinical development, process development, manufacturing & clinical development. Research-relevant quantities of the original drug are available as aliquot or dilution.

Therapeutic molecule
Antigen
Price range
to GO
Filters Sort results
Drug name
Therapeutic molecule
All molecules shown in this table are clinically approved by an international regulatory institution. However, all products sold by Evientic are for analytical / pre-clinical use only. Human use is prohibited! At this time (01/2020) all molecules available from Evidentic are licensed in the EU market.
Antigen
Manufacturer's CoA available
What is a CoA?
CoA is the abbreviation for 'Certificate of Analysis'. This document is in some cases supplied with originally manufactured pharmaceutical products, i.e. a drug. However, manufacturers of medicinal products for human use are not obliged to supply these documents and it therefore not easy to obtain the additional document. This document provides some basic data of a particular batch release and may help analytical scientists to prepare their characterization study. A new CoA is issued with each batch release of a manufacturer. Customers can purchase the available CoA for an additional charge. Legend: yes : CoAs for this product are available no : no CoA for each available batch no / yes: for most/some batches of a specific product CoAs can be obtained from Evidentic.
Bevacizumab
VEGF-A
no
yes
Avelumab
PD-L1
no
Adalimumab
Atezolizumab
Avelumab
Bevacizumab
Cetuximab
Daratumumab
Denosumab
Durvalumab
Etanercept
Golimumab
Infliximab
Ipilimumab
Nivolumab
Obinutuzumab
Palivizumab
Pembrolizumab
Pertuzumab
Ramucirumab
Rituximab
Secukinumab
Tocilizumab
Trastuzumab
Ustekinumab
no
yes
Secukinumab
IL 17A
no
Ramucirumab
VEGFR2
no
Daratumumab
CD38
no
Etanercept
TNF-α
no
Cetuximab
EGFR
no
Obinutuzumab
CD20
no
Trastuzumab
HER2
no
Adalimumab
TNF-α
no
yes
Durvalumab
PD-L1
no
Pembrolizumab
PD-1
no
yes
Rituximab
CD20
no
Nivolumab
PD-1
no
Pertuzumab
HER2
no
yes
Denosumab
RANKL
no
Infliximab
TNF-α
no
Tocilizumab
IL-6 R
no
Golimumab
TNF-α
no
Ustekinumab
IL-12
no
Palivizumab
RSV protein F
no
yes
Atezolizumab
PD-L1
yes
Ipilimumab
CD152
CTLA4
no
yes

Showing all 24 results